Acousia Therapeutics GmbH

Acousia Therapeutics GmbH

Drug development against hearing loss

The company develops small molecule drugs for the treatment of hearing loss in patients that have lost their hearing ability due tu various reasons e. g. noise trauma, treatment with ototoxic drugs (chemotherapeutics) or age-related decrease in hearing capacity.

Category

Biotechnology

Activity Development, Pharmacy

Management

Dr. Michael Bös

Year of foundation

2012

Employees

2

Supervisory board

Dr. Frank Kalkbrenner, Prof. Dr. Hubert Löwenheim

Advisory board

Prof. Takayuki Nakagawa, Prof. Helge Rask-Andersen, Prof. Donald Craig

Funding

€ 4.5M